Business

Boston Scientific loses $73 million in first mesh case defeat

Boston Scientific has been ordered to pay $73 million to a woman who said a defectively designed vaginal-mesh implant left her in constant pain, in the first award against the device maker over its incontinence slings.

Boston Scientific is liable for Martha Salazar’s injuries, which she blamed on the company’s Obtryx sling, jurors in Texas state court in Dallas said on Monday. They awarded her about $23 million in compensatory damages and $50 million in punitive damages, according to a court filing.

Advertisement

Boston Scientific had won the first two cases to reach trial over the sling. The Natick, Mass.-based company faces more than 12,000 lawsuits in which women contend its vaginal mesh implants, including the slings, erode within the body. Organs may be damaged and pain can result, requiring surgery to remove the device, according to patients who sued.

‘‘This woman was seeking help with minor urine leakage and wound up with a catastrophic, life-altering injury that required four major surgeries,’’ Salazar’s lawyer, Dave Matthews, said in a telephone interview. ‘‘It’s a tragedy that these slings are still on the market.’’

Get Talking Points in your inbox:
An afternoon recap of the day’s most important business news, delivered weekdays.
Thank you for signing up! Sign up for more newsletters here

Matthews said his client, a former property manager, can no longer sit comfortably or walk or exercise normally as a result of her injuries. Boston Scientific disagrees with the verdict and will appeal, said Kelly Leadem, a company spokeswoman.

The US Food and Drug Administration ordered Boston Scientific, Johnson & Johnson, and more than 30 other vaginal-implant makers in 2012 to study rates of organ damage and complications linked to the products. Many of the cases against Boston Scientific, J&J and C.R. Bard have been consolidated before US District Judge Joseph Goodwin in Charleston, W.Va. Others have been filed in state courts in Delaware, New Jersey, Massachusetts, Missouri, Texas, and California.

Boston Scientific and other makers of vaginal inserts targeted in suits had talks this year about settling cases over the devices, according to people familiar with the discussions.

Advertisement

Endo International agreed in April to pay $830 million to resolve about 20,000 lawsuits alleging that its vaginal-mesh inserts eroded in some women and left them incontinent and in pain.

In Salazar’s case, the Dallas jury returned with a verdict the same day it began deliberations, finding that Boston Scientific’s sling suffered from a faulty design. The panel also found company officials failed to properly warn patients and doctors about the insert’s health risks.

Jurors said Boston Scientific’s handling of the slings amounted to gross negligence, which Mathews said allowed the jury to award punitive damages.

During the two-week trial before Texas District Judge Ken Molberg, Matthews said he asked the jury to award Salazar $14 million for her injuries and her pain and suffering.

As part of the evidence in the case, Matthews presented an August 2000 e-mail from Alex Robbins, a Boston Scientific executive, in which he tells salespeople to ignore a company-funded study raising questions about the sling’s safety.

‘‘I certainly wouldn’t hand this out to any physicians,’’ Robbins said in the e-mail.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.